Scientists at AstraZeneca, one of the world’s most successful pharmaceutical companies, have been working with the University of Cambridge for more than two decades.
Cambridge and Boeing have been working together for 20 years. Today they are combining their research strengths and industry know-how to speed aviation towards a carbon-neutral future.
Cambridge and BT have been working together for more than 25 years developing new technologies, exploring human behaviour and considering how those two things come together to shape our world.
Wearable technologies will play an important part in the healthcare delivery of the future. Cambridge and Nokia Bell Labs are working together to build the foundations of these transformative technologies.
Cambridge's Experimental Medicine Initiative, supported by AstraZeneca and GSK, is training specialists to find out much earlier in clinical trials if a new treatment is likely to be effective.
Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.
An award-winning team from Cambridge, Botswana, Mozambique and Namibia has been bolstering entrepreneurship in Southern Africa and supporting some exciting new ventures along the way.
The University provides a wide range of executive education programmes and lifelong learning. Moving all this online during a pandemic has led to the development of a new range of courses for professionals, Cambridge Advance Online.
